1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2018-2032)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2018-2023)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2032)
2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2018-2023)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2018-2023)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2032)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Detail
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Detail
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Detail
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details